Medicines to prevent respiratory syncytial virus (RSV) infection

Content provided by Healthwise

Medicines to prevent respiratory syncytial virus (RSV) infection

Preventive medicines are usually used only for babies and children who have a higher risk of having complications if they become infected with respiratory syncytial virus (RSV). These medicines are not used to treat someone who already has RSV infection.

Palivizumab (Synagis) is a medicine containing laboratory-produced antibodies designed to help prevent RSV infections. RSV infections that develop despite being given this medicine are usually less severe. Palivizumab is given by injection into the muscle (intramuscular, or IM) once a month during the winter months.

No standard preventive immunization exists because there is more than one type of RSV and many subtypes (strains). Researchers are trying to develop a vaccine that is effective for the general population at a reasonable cost.

Credits

Print Email SHARE

Author	Debby Golonka, MPH
Editor	Susan Van Houten, RN, BSN, MBA
Associate Editor	Pat Truman, MATC
Primary Medical Reviewer	Michael J. Sexton, MD - Pediatrics
Specialist Medical Reviewer	W. David Colby IV, MSc, MD, FRCPC - Infectious Disease
Last Updated	July 16, 2008

Print Email Twitter Facebook MySpace AIM More

Last updated:	July 16, 2008
Author:	Debby Golonka, MPH
Reviewed By:	Michael J. Sexton, MD - Pediatrics, W. David Colby IV, MSc, MD, FRCPC - Infectious Disease
Editors:	Susan Van Houten, RN, BSN, MBA, Pat Truman, MATC

This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.